This information has been collated from the Medsafe New Zealand website. Each situation is different, and advice should be taken with caution.
Neither sodium picosulfate nor magnesium citrate has been shown to be excreted in breast milk. As there is no experience with the use of PICOSALAX in nursing mothers, the product should only be used if clearly indicated.
Whilst animal reproduction studies with sodium picosulfate have revealed no evidence of a harmful action on the foetus, clinical experience of the use of PICOSALAX during pregnancy is limited and caution should be observed, particularly during the first trimester.
Last reviewed 20th June 2017